Exact Mass: 233.0453072
Exact Mass Matches: 233.0453072
Found 500 metabolites which its exact mass value is equals to given mass value 233.0453072,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Sulbactam
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CG - Beta-lactamase inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D065093 - beta-Lactamase Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C2140 - Adjuvant > C183118 - Beta-lactamase Inhibitor D004791 - Enzyme Inhibitors
2-Hydroxy-6-oxo-(2-aminophenyl)-hexa-2,4-dienoate
Casimiroin
Casimiroin is found in pomes. Casimiroin is an alkaloid from the seed and bark of Casimiroa edulis (Mexican apple). Alkaloid from the seed and bark of Casimiroa edulis (Mexican apple). Casimiroin is found in pomes.
Dopamine 3-O-sulfate
Dopamine 3-O-sulfate is a sulfonated form of dopamine. In human blood circulation endogenous dopamine exists predominantly in the sulfated form and dopamine sulfate accounts for more than 90\\% of all dopamine. Dopamine-3-O-sulfate predominates in human plasma, with concentrations about 10-fold higher than those of the regioisomer dopamine-4-O-sulfate. Sulfonation is the most important metabolic pathway that interferes with the binding of dopamine to its receptors. The origins of this preponderance for Dopamine-3-O-sulfate have not been determined, although there has been speculation about the contribution of the specificity of transport proteins and/or arylsulfatases. It has also been proposed to depend on the regiospecificity of the metabolizing enzyme(s) for the 3-hydroxy group of dopamine. It is believed that the vast majority of circulating dopamine sulfate originates in the upper gastrointestinal tract, and indeed that is the main site of expression of the enzyme responsible for its formation. Aryl sulfotransferase (SULT1A3, EC 2.8.2.1) is an enzyme that catalyzes the sulfonation of many endogenous and exogenous phenols and catechols; the most important endogenous substrate is dopamine. SULT1A3 strongly favors the 3-hydroxy group of dopamine over the 4-hydroxy group and may indeed be primarily responsible for the difference between the circulating levels of dopamine sulfates in human blood. (PMID: 17548063) [HMDB] Dopamine 3-O-sulfate is a sulfonated form of dopamine. In human blood circulation endogenous dopamine exists predominantly in the sulfated form and dopamine sulfate accounts for more than 90\\% of all dopamine. Dopamine-3-O-sulfate predominates in human plasma, with concentrations about 10-fold higher than those of the regioisomer dopamine-4-O-sulfate. Sulfonation is the most important metabolic pathway that interferes with the binding of dopamine to its receptors. The origins of this preponderance for Dopamine-3-O-sulfate have not been determined, although there has been speculation about the contribution of the specificity of transport proteins and/or arylsulfatases. It has also been proposed to depend on the regiospecificity of the metabolizing enzyme(s) for the 3-hydroxy group of dopamine. It is believed that the vast majority of circulating dopamine sulfate originates in the upper gastrointestinal tract, and indeed that is the main site of expression of the enzyme responsible for its formation. Aryl sulfotransferase (SULT1A3, EC 2.8.2.1) is an enzyme that catalyzes the sulfonation of many endogenous and exogenous phenols and catechols; the most important endogenous substrate is dopamine. SULT1A3 strongly favors the 3-hydroxy group of dopamine over the 4-hydroxy group and may indeed be primarily responsible for the difference between the circulating levels of dopamine sulfates in human blood. (PMID: 17548063).
Dopamine 4-sulfate
Dopamine 4-sulfate is one of the metabolic products of the endogenous catecholamine dopamine which have also been implicated as intermediate in noradrenaline biosynthesis. In human blood circulation endogenous dopamine exists predominantly in the sulfated form and dopamine sulfate accounts for more than 90\\% of all dopamine. Sulfonation is the most important metabolic pathway that interferes with the binding of dopamine to its receptors. Dopamine-4-O-sulfate has concentrations about a 10th of those of the regioisomer dopamine-3-O-sulfate. It is believed that the vast majority of circulating dopamine sulfate originates in the upper gastrointestinal tract, and indeed that is the main site of expression of the enzyme responsible for its formation. Aryl sulfotransferase (SULT1A3, EC 2.8.2.1) is an enzyme that catalyzes the sulfonation of many endogenous and exogenous phenols and catechols; the most important endogenous substrate is dopamine. SULT1A3 strongly favors the 3-hydroxy group of dopamine over the 4-hydroxy group and may indeed be primarily responsible for the difference between the circulating levels of dopamine sulfates in human blood. (PMID: 17548063) [HMDB] Dopamine 4-sulfate is one of the metabolic products of the endogenous catecholamine dopamine which have also been implicated as intermediate in noradrenaline biosynthesis. In human blood circulation endogenous dopamine exists predominantly in the sulfated form and dopamine sulfate accounts for more than 90\\% of all dopamine. Sulfonation is the most important metabolic pathway that interferes with the binding of dopamine to its receptors. Dopamine-4-O-sulfate has concentrations about a 10th of those of the regioisomer dopamine-3-O-sulfate. It is believed that the vast majority of circulating dopamine sulfate originates in the upper gastrointestinal tract, and indeed that is the main site of expression of the enzyme responsible for its formation. Aryl sulfotransferase (SULT1A3, EC 2.8.2.1) is an enzyme that catalyzes the sulfonation of many endogenous and exogenous phenols and catechols; the most important endogenous substrate is dopamine. SULT1A3 strongly favors the 3-hydroxy group of dopamine over the 4-hydroxy group and may indeed be primarily responsible for the difference between the circulating levels of dopamine sulfates in human blood. (PMID: 17548063).
Brassicanal B
Brassicanal B is found in brassicas. Brassicanal B is an alkaloid from Chinese cabbage Brassica campestris ssp. pekinensis inoculated with Pseudomonas cichorii. Alkaloid from Chinese cabbage Brassica campestris sspecies pekinensis inoculated with Pseudomonas cichorii. Brassicanal B is found in brassicas.
1-Hydroxy-2-(N-acetylcysteinyl)-3-butene
4-(3-Pyridin-2-yl-[1,2,4]oxadiazol-5-yl)-butyric acid
Aminobutane bisphosphonate
D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates
Hydroxyaniline mustard
D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds
(2R)-2-Acetamido-6-hydroxy-2-(sulfanylmethyl)hex-3-enoic acid
4,5Dimethyl-3-(2-oxo-2-phenyl-ethyl)-thiazole
C13H15NOS (233.08742999999998)
(2S)-2-[(2-Carboxy-2-oxoethyl)amino]pentanedioic acid
Dicarbamoyl (2S)-2-aminopentanedioate
4-Amino-3-phenyl-2-thioxo-2,3-dihydro-1,3-thiazole-5-carbonitrile
1-(5-anilino-1,2,4-thiadiazol-3-yl)acetone
C11H11N3OS (233.06227959999998)
5-Benzotriazol-1-ylmethyl-[1,3,4]oxadiazole-2-thiol
2-Aminodiphenylsulfone
CONFIDENCE standard compound; INTERNAL_ID 477; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7924; ORIGINAL_PRECURSOR_SCAN_NO 7921 CONFIDENCE standard compound; INTERNAL_ID 477; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7962; ORIGINAL_PRECURSOR_SCAN_NO 7959 CONFIDENCE standard compound; INTERNAL_ID 477; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7964; ORIGINAL_PRECURSOR_SCAN_NO 7961 CONFIDENCE standard compound; INTERNAL_ID 477; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8002; ORIGINAL_PRECURSOR_SCAN_NO 7999 CONFIDENCE standard compound; INTERNAL_ID 477; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8006; ORIGINAL_PRECURSOR_SCAN_NO 8003 CONFIDENCE standard compound; INTERNAL_ID 477; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8013; ORIGINAL_PRECURSOR_SCAN_NO 8010
Benzenesulfonanilide
CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 1060
1-(hydroxymethyl)-7-methoxy-6-methylisoquinoline-5,8-dione
ethyl 2,3-dioxo-1,4-dihydroquinoline-4-carboxylate
ethyl 2,3-dioxo-1,4-dihydroquinoline-4-carboxylate
Aminodiphenylsulfone
CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 1009
5-Acetoacetamino benzimidazolone
CONFIDENCE standard compound; INTERNAL_ID 387; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2379; ORIGINAL_PRECURSOR_SCAN_NO 2376 CONFIDENCE standard compound; INTERNAL_ID 387; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2374; ORIGINAL_PRECURSOR_SCAN_NO 2372 CONFIDENCE standard compound; INTERNAL_ID 387; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2378; ORIGINAL_PRECURSOR_SCAN_NO 2375 CONFIDENCE standard compound; INTERNAL_ID 387; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2368; ORIGINAL_PRECURSOR_SCAN_NO 2365 CONFIDENCE standard compound; INTERNAL_ID 387; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2441; ORIGINAL_PRECURSOR_SCAN_NO 2438 CONFIDENCE standard compound; INTERNAL_ID 387; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2381; ORIGINAL_PRECURSOR_SCAN_NO 2378
Diloxanide
C9H9Cl2NO2 (233.00103140000002)
P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01A - Agents against amoebiasis and other protozoal diseases > P01AC - Dichloroacetamide derivatives D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
Ethyl 2,3-dioxo-1,2,3,4-tetrahydro-4-quinolinecarboxylate
Propanamide, 2-chloro-N-(5-chloro-2-hydroxyphenyl)-
C9H9Cl2NO2 (233.00103140000002)
2-chloro-N-(4-methoxyphenyl)aniline
C13H12ClNO (233.06073719999998)
Ethyl 5-(2-fluorophenyl)-1H-pyrrole-3-carboxylate
C13H12FNO2 (233.08520240000001)
4-(1H-INDOL-6-YL)-TETRAHYDRO-2H-THIOPYRAN-4-OL
C13H15NOS (233.08742999999998)
2-CHLORO-4-BENZYLAMINO-5-METHYLPYRIMIDINE
C12H12ClN3 (233.07197019999998)
3-Amino-3-(3,4-dichlorophenyl)propanoic acid
C9H9Cl2NO2 (233.00103140000002)
3-Amino-3-(3,5-dichlorophenyl)propanoic acid
C9H9Cl2NO2 (233.00103140000002)
Ethyl 4,6-dichloro-2-methylnicotinate
C9H9Cl2NO2 (233.00103140000002)
N-(2,6-Dichloro-4-methoxyphenyl)acetamide
C9H9Cl2NO2 (233.00103140000002)
3,4-dichloro phenyl glycine methyl ester
C9H9Cl2NO2 (233.00103140000002)
1-FLUORO-5-METHYL-4-(METHYLSULFONYL)-2-NITROBENZENE
6-Methyl-2-phenyl-1,3,6,2-dioxazaborocane-4,8-dione
1H-Indole-1-aceticacid, 2,3-dihydro-2,3-dioxo-, ethyl ester
6-ACETAMIDO-1-OXO-2,3-DIHYDRO-1H-INDENE-4-CARBOXYLIC ACID
2-PYRIMIDINAMINE, 4-CHLORO-6-METHYL-5-(PHENYLMETHYL)-
C12H12ClN3 (233.07197019999998)
2-tert-Butylamino-1-(4-chloro-2-thienyl)ethanol
C10H16ClNOS (233.06410759999997)
ethyl 6-fluoro-2-methylquinoline-3-carboxylate
C13H12FNO2 (233.08520240000001)
2-Chloro-N-(5-chloro-2-methoxyphenyl)acetamide
C9H9Cl2NO2 (233.00103140000002)
3-(3,5-dichloroanilino)propanoic acid
C9H9Cl2NO2 (233.00103140000002)
METHYL 2-(2-AMINO-4-(TRIFLUOROMETHYL)PHENYL)ACETATE
3-AMINO-3-(2-TRIFLUOROMETHYL-PHENYL)PROPIONIC ACID
1H-Isoindole-1,3(2H)-dione,2-(4-chloro-2-butyn-1-yl)-
2H-Isoindole-2-aceticacid, a-ethyl-1,3-dihydro-1,3-dioxo-
(2-Bromo-pyridin-4-ylmethyl)-isopropyl-amine
C8H12ClN3OS (233.03895719999997)
BENZENEACETAMIDE, 4-HYDROXY-N-METHYL-
C13H12ClNO (233.06073719999998)
2-ethyl-6-fluoro-3-methylquinoline-4-carboxylic acid
C13H12FNO2 (233.08520240000001)
3-phenylpyridine-2-carboximidamide,hydrochloride
C12H12ClN3 (233.07197019999998)
6-Phenylpicolinimidamide hydrochloride
C12H12ClN3 (233.07197019999998)
4-Phenylpicolinimidamide hydrochloride
C12H12ClN3 (233.07197019999998)
5-Phenylpicolinimidamide hydrochloride
C12H12ClN3 (233.07197019999998)
N-benzyl-6-chloro-N-methylpyridazin-3-amine
C12H12ClN3 (233.07197019999998)
5-(4-Hydroxyphenyl)-4-oxazolecarboxylic acid ethyl ester
N-(4,5,6,7-tetrahydro-[1,3]thiazolo[5,4-c]pyridin-2-yl)acetamide,hydrochloride
C8H12ClN3OS (233.03895719999997)
Mofegiline hydrochloride
D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D004791 - Enzyme Inhibitors > D008996 - Monoamine Oxidase Inhibitors C471 - Enzyme Inhibitor > C667 - Monoamine Oxidase Inhibitor
2H-Isoindole-2-aceticacid, 1,3-dihydro-1,3-dioxo-, ethyl ester
1H-Isoindole-1,3(2H)-dione,2-[(trimethylsilyl)methyl]-
3,5-DIMETHOXY-4-HYDROXYPHENETHYLAMINEHYDROCHLORIDE
(r)-3-amino-4-(2-fluorophenyl)butanoic acid hydrochloride
C10H13ClFNO2 (233.06188000000003)
N-(2,4-Dichloro-5-methoxyphenyl)acetamide
C9H9Cl2NO2 (233.00103140000002)
2-[(2-CHLORO-PHENYLAMINO)-METHYL]-PHENOL
C13H12ClNO (233.06073719999998)
1-[(Cyanocarbonothioyl)(methylcarbamoyl)amino]-4-methylbenzene
C11H11N3OS (233.06227959999998)
1-(cyanocarbothioyl)-3-methyl-1-(3-methylphenyl)urea
C11H11N3OS (233.06227959999998)
(1R,2R)-(-)-2-BENZYLOXYCYCLOPENTYL ISOTHIOCYANATE
C13H15NOS (233.08742999999998)
4-(1-HYDROXY-2-(METHYLAMINO)ETHYL)-2-METHOXYPHENOL HYDROCHLORIDE
2-amino-5-phenylthiophene-3-carbohydrazide
C11H11N3OS (233.06227959999998)
2-chloro-N-(4-chloro-3-methoxyphenyl)acetamide
C9H9Cl2NO2 (233.00103140000002)
3-(TERT-BUTOXYCARBONYL)THIAZOLIDINE-2-CARBOXYLIC ACID
7-Methoxy-4-oxo-1,4-dihydro-quinoline-2-carboxylic acid methyl ester
1-Acetyl-2,3-dihydro-2-oxo-1H-indole-6-carboxylic acid methyl ester
1H-1,2,4-Triazole-1-aceticacid,4,5-dihydro-4-(4-methylphenyl)-5-oxo-
tert-butyl (2S)-2-(2-chloroacetyl)azetidine-1-carboxylate
ethyl 5,6-dichloro-2-methylpyridine-3-carboxylate
C9H9Cl2NO2 (233.00103140000002)
n-(4-(4-amino-3,5-thiazolyl)phenyl)ethanamide
C11H11N3OS (233.06227959999998)
2-AMINO-6-CHLORO-1,2,3,4-TETRAHYDRO-NAPHTHALEN-1-OL HYDROCHLORIDE
3-(4-Chlorobutyl)indole-5-carbonitrile
C13H15NOS (233.08742999999998)
4-methyl-2-phenyl-1,3-thiazole-5-carbohydrazide
C11H11N3OS (233.06227959999998)
Ethyl2,5-dihydro-5-oxo-1-phenyl-1H-1,2,4-triazole-3-carboxylate
2-Chloro-N,N-dimethyl-5-phenylpyrimidin-4-amine
C12H12ClN3 (233.07197019999998)
2,4-DICHLORO-N-(2-HYDROXYETHYL)BENZENECARBOXAMIDE
C9H9Cl2NO2 (233.00103140000002)
3-(2-METHOXYPHENYL)-5-METHYLISOXAZOLE-4-CARBOXYLIC ACID
N-(5-BUTYL-[1,3,4]THIADIAZOL-2-YL)-2-CHLORO-ACETAMIDE
C8H12ClN3OS (233.03895719999997)
ethyl 5-chloro-3-(methylsulfanyl)-1,2,4-triazine-6-carboxylate
1-(4-FLUORO-BENZYL)-PIPERAZINE2HCL
C13H12FNO2 (233.08520240000001)
(1S,2S)-(+)-2-BENZYLOXYCYCLOPENTYL ISOTHIOCYANATE
C13H15NOS (233.08742999999998)
(s)-3-amino-3-(3-trifluoromethyl-phenyl)-propionic acid
3-Pyridinecarboxylic acid, 1-(4-fluorophenyl)-1,2-dihydro-2-oxo-
C12H8FNO3 (233.04881899999998)
Methyl 1,4-Dihydro-6-Methoxy-4-oxo-quinoline-7-carboxylate
Methyl 7-Methoxy-4-oxo-1,4-dihydroquinoline-6-carboxylate
(2-Amino-4-methyl-5-thiazolyl)phenylmethanoneoxime
C11H11N3OS (233.06227959999998)
(r)-3-amino-4-(4-fluorophenyl)butanoic acid hydrochloride
C10H13ClFNO2 (233.06188000000003)
3-Pyridazinamine, 6-[(2-methoxyphenyl)thio]-
C11H11N3OS (233.06227959999998)
BU 224 hydrochloride,2-(4,5-Dihydroimidazol-2-yl)quinolinehydrochloride
C12H12ClN3 (233.07197019999998)
2-chloro-N-(2-phenylethyl)pyrimidin-4-amine
C12H12ClN3 (233.07197019999998)
4-(1,3-dioxo-1,3-dihydro-2h-isoindol-2-yl)butanoic acid
Benzoic acid,2-[(2-aminoethyl)thio]-, hydrochloride (1:1)
4-Quinolinecarboxylicacid, 1,2-dihydro-3-hydroxy-2-oxo-, ethyl ester
3-[(4-CHLOROPHENYL)METHOXY]-AZETIDINE HYDROCHLORIDE
3-Amino-3-(2,4-dichlorophenyl)propanoic acid
C9H9Cl2NO2 (233.00103140000002)
1-(2-CHLOROPHENYL)-2,5-DIMETHYL-1H-PYRROLE-3-CARBALDEHYDE
C13H12ClNO (233.06073719999998)
4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-ol,acetate,hydrochloride
acitazanolast
C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent
Ethyl 2,4-dichloro-6-methylnicotinate
C9H9Cl2NO2 (233.00103140000002)
4-(1H-INDOL-5-YL)-TETRAHYDRO-THIOPYRAN-4-OL
C13H15NOS (233.08742999999998)
4h-1-benzopyran-2-carboxylic acid, 6-amino-4-oxo-, ethyl ester
3-BROMO-2-HYDROXY-5-METHYLPYRIDINE
C13H12FNO2 (233.08520240000001)
(r)-3-amino-4-(3-fluorophenyl)butanoic acid hydrochloride
C10H13ClFNO2 (233.06188000000003)
3-amino-3-(4-trifluoromethyl-phenyl)-propionic acid
(R)-3-Amino-3-(2-trifluoromethyl-phenyl)-propionic acid
ethyl 2-(4-amino-3-fluorophenyl)-2,2-difluoroacetate
Ethyl 2,6-dichloro-4-methylnicotinate
C9H9Cl2NO2 (233.00103140000002)
2-(7-fluoro-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid
C13H12FNO2 (233.08520240000001)
3-(4-CHLORO-3-METHYL-PHENOXY)-PHENYLAMINE
C13H12ClNO (233.06073719999998)
2-[5-methyl-2-(4-methylphenyl)-1,3-thiazol-4-yl]ethanol
C13H15NOS (233.08742999999998)
1-(4-fluorophenoxy)-2-nitrobenzene
C12H8FNO3 (233.04881899999998)
1-ACETYL-2-OXO-2,3-DIHYDRO-1H-INDOLE-5-CARBOXYLIC ACID METHYL ESTER
N-(3,5-dichloro-2-hydroxy-4-methylphenyl)acetamide
C9H9Cl2NO2 (233.00103140000002)
3-Amino-3-(2,5-dichlorophenyl)propanoic acid
C9H9Cl2NO2 (233.00103140000002)
3-(2-METHYL-THIAZOL-4-YL)-BENZOIC ACID METHYL ESTER
2-Chloro-4-(pyrrolidin-1-yl)quinazoline
C12H12ClN3 (233.07197019999998)
4-(4-CHLORO-BENZYLOXY)-PHENYLAMINE
C13H12ClNO (233.06073719999998)
3,4-dichlorobenzyl methylcarbamate
C9H9Cl2NO2 (233.00103140000002)
N-(3-bromo-4-oxocyclohexyl)acetamide
C8H12BrNO2 (233.00513519999998)
6-Benzyl-3-(methylsulfanyl)-1,2,4-triazin-5(2H)-one
C11H11N3OS (233.06227959999998)
4-(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)butanoic acid
2,3-dihydro-6-(trifluoromethyl)benzo[1,4]-thiazin-3-one
C9H6F3NOS (233.01221819999998)
3-Isoquinolinecarboxylicacid, 1,2-dihydro-4-hydroxy-1-oxo-, ethyl ester
4-Chloro-8-methoxy-5H-pyrimido[5,4-b]indole
C11H8ClN3O (233.03558679999998)
3-(2,3-DICHLOROPHENYL)-BETA-ALANINE
C9H9Cl2NO2 (233.00103140000002)
Methyl 2-amino-5-methyl-4-(trifluoromethyl)benzoate
(R)-METHYL 2-AMINO-3-(4-FLUOROPHENYL)PROPANOATE HYDROCHLORIDE
C10H13ClFNO2 (233.06188000000003)
Ethyl 2-amino-4,5-dichlorobenzoate
C9H9Cl2NO2 (233.00103140000002)
2-AMINO-1-(4-CHLORO-PHENYL)-5-OXO-4,5-DIHYDRO-1H-PYRROLE-3-CARBONITRILE
C11H8ClN3O (233.03558679999998)
(R)-3-Amino-3-(2,3-dichloro-phenyl)-propionic acid
C9H9Cl2NO2 (233.00103140000002)
8-CHLORO-3-METHYL-2H-PYRAZOLO[4,3-C]QUINOLIN-4(5H)-ONE
C11H8ClN3O (233.03558679999998)
2-CHLORO-N-(5-ISOBUTYL-[1,3,4]THIADIAZOL-2-YL)-ACETAMIDE
C8H12ClN3OS (233.03895719999997)
1,1-DIOXIDO-3,4-DIHYDRO-2H-THIOCHROMEN-4-YLAMINE HYDROCHLORIDE
Ethyl 2-(4-hydroxyphenyl)-1,3-oxazole-4-carboxylate
6-chloro-N-(2-phenylethyl)pyridazin-3-amine
C12H12ClN3 (233.07197019999998)
alpha-(Aminomethyl)-2,5-dimethoxybenzyl alcohol hydrochloride
6-(methoxycarbonyl)-3-methyl-1H-indole-2-carboxylic acid
3-(4-METHOXYPHENYL)-5-METHYL-4-ISOXAZOLECARBOXYLIC ACID
1-(4-Methoxy-benzyl)-1H-[1,2,3]triazole-4-carboxylic acid
2-chloro-n-(3-chloro-4-methoxyphenyl)acetamide
C9H9Cl2NO2 (233.00103140000002)
6-Fluoro-2,3,4,9-tetrahydro-1H-carbazole-3-carboxylic acid
C13H12FNO2 (233.08520240000001)
Ethyl N-(3,4-dichlorophenyl)carbamate
C9H9Cl2NO2 (233.00103140000002)
(S)-3-Amino-3-(2-(trifluoromethyl)phenyl)propanoic acid
(R)-3-Amino-3-(2,4-dichloro-phenyl)-propionic acid
C9H9Cl2NO2 (233.00103140000002)
N-(4,6-Dimethylpyrimidin-2-yl)-2-thienylformamide
C11H11N3OS (233.06227959999998)
methyl (E)-3-(furan-2-yl)-2-(1,2,4-triazol-1-ylmethyl)prop-2-enoate
3-(4-fluorophenyl)-5-nitropyridin-4-amine
C11H8FN3O2 (233.06005199999998)
ethyl 3-amino-4,4,5,5,5-pentafluoropent-2-enoate
C7H8F5NO2 (233.04751679999998)
4-[(E)-phenyldiazenyl]aniline hydrochloride
C12H12ClN3 (233.07197019999998)
Benzenemethanamine,N-(3-chloropropyl)-N-methyl-, hydrochloride (1:1)
C11H17Cl2N (233.07379820000003)
3-amino-3-[3-(trifluoromethyl)phenyl]propanoic acid
(s)-3-amino-4-(2-fluorophenyl)butanoic acid hydrochloride
C10H13ClFNO2 (233.06188000000003)
Dimaprit dihydrochloride
Dimaprit dihydrochloride is a selective histamine H2 receptor agonist, it also inhibits nNOS with an IC50 of 49 μM. Dimaprit dihydrochloride can stimulate gastric acid secretion[1][2].
2-(1-thienyl)ethyl 3,4-dihydroxybenzylidenecyanoacetate
4-Methyl-2-(4-methylphenyl)-1,3-thiazole-5-carboxylic acid
2-(N-Morpholino)ethanesulfonic acid potassium salt
C6H12KNO4S (233.01240919999998)
(s)-3-amino-4-(3-fluorophenyl)butanoic acid hydrochloride
C10H13ClFNO2 (233.06188000000003)
(s)-3-amino-4-(4-fluorophenyl)butanoic acid hydrochloride
C10H13ClFNO2 (233.06188000000003)
(R)-3-Amino-3-(3-(trifluoromethyl)phenyl)propanoic acid
METHYL 6-METHOXY-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLATE
5,6-DIHYDROXY-2-PYRIDIN-2-YL-PYRIMIDINE-4-CARBOXYLIC ACID
3-(1-methylsulfonylpiperidin-4-yl)prop-2-enoic acid
(PYRAZIN-2-YL)METHANAMINEHYDROCHLORIDE
C11H11N3OS (233.06227959999998)
2-Methyl-6-(trifluoromethoxy)benzothiazole
C9H6F3NOS (233.01221819999998)
(S)-3-Amino-3-(2,4-dichloro-phenyl)-propionic acid
C9H9Cl2NO2 (233.00103140000002)
(S)-3-Amino-3-(2,3-dichloro-phenyl)-propionic acid
C9H9Cl2NO2 (233.00103140000002)
5-Isoxazolecarboxylic acid, 3-(4-Methoxyphenyl)-, Methyl ester
Methyl (1S,5R)-8-methyl-3-oxo-8-azabicyclo[3.2.1]octane-2-carboxylate hydrochloride (1:1)
IMIDAZO[1,2-A]PYRIDIN-2-YLMETHYL-METHYL-AMINE DIHYDROCHLORIDE
(2S)-2-[3-FLUORO-4-(TRIFLUOROMETHYL)PHENYL]PYRROLIDINE
(2S)-2-[5-FLUORO-2-(TRIFLUOROMETHYL)PHENYL]PYRROLIDINE
(S)-Pyrrolidin-3-yl-(1-thiazol-2-yl-ethyl)-aMine hydrochloride
(S)-3-Amino-4-(2-Fluorophenyl)butyric Acid Hydrochloride
C10H13ClFNO2 (233.06188000000003)
(R)-Pyrrolidin-3-yl-(1-thiazol-2-yl-ethyl)-aMine hydrochloride
N-cyclopropyl-3,4-difluorobenzenesulfonaMide
C9H9F2NO2S (233.03220380000002)
3,4-DICHLORO-N-(2-HYDROXYETHYL)BENZENECARBOXAMIDE
C9H9Cl2NO2 (233.00103140000002)
2-amino-5-chloro-diphenyl methanol
C13H12ClNO (233.06073719999998)
(4-CHLORODIPHENYL)METHYLBETA-CHLOROETHYLETHER
C13H12ClNO (233.06073719999998)
Benzoic acid,4-amino-3,5-dichloro-, ethyl ester
C9H9Cl2NO2 (233.00103140000002)
5-(dimethylsulfamoyl)-2-methylfuran-3-carboxylic acid
5-Chloro-2-(3-methylphenoxy)aniline
C13H12ClNO (233.06073719999998)
2-Phenoxy-N-(2-thienylmethyl)-1-ethanamine
C13H15NOS (233.08742999999998)
Methyl 2-(5-hydroxy-1-(pyridin-2-yl)-1H-pyrazol-3-yl)acetate
methyl 2-amino-3-(4-fluorophenyl)propanoate,hydrochloride
C10H13ClFNO2 (233.06188000000003)
5-Amino-1-(4-methoxyphenyl)-1H-pyrazole-4-carboxylic acid
5-(BENZYLOXY)-2-(CHLOROMETHYL)PYRIDINE
C13H12ClNO (233.06073719999998)
4-(1,3-dithiolan-2-yl)aniline hydrochloride
C9H12ClNS2 (233.00996619999998)
5-(4-Methoxyphenyl)-3-(methylthio)-1,2,4-triazine
C11H11N3OS (233.06227959999998)
2-Chloro-10-methyl-3,4-diazaphenoxazine
C11H8ClN3O (233.03558679999998)
N-(6-chloro-2-phenyl-4-pyrimidinyl)-N,N-dimethylamine
C12H12ClN3 (233.07197019999998)
N-(6-Chloro-2-phenyl-4-pyrimidinyl)-N-ethylamine
C12H12ClN3 (233.07197019999998)
1-(4-CHLOROPHENYL)-2-(4-METHYLPHENYL)ETHANE-1,2-DIONE
C13H12ClNO (233.06073719999998)
2-AMINO-4-METHYL-N-PHENYLTHIAZOLE-5-CARBOXAMIDE
C11H11N3OS (233.06227959999998)
N-[4-(3-Aminophenyl)-2-thiazolyl]acetamide
C11H11N3OS (233.06227959999998)
4-Hydroxy-7-methoxy-quinoline-2-carboxylic acid methyl ester
2,1,3-Benzoxadiazol-5-yl(morpholin-4-yl)methanone
CX 717 is a positive allosteric modulator of AMPA receptor. Antidepressant-like effect. CX 717 can be used for the research of adult attention deficit hyperactivity disorder (ADHD)[1][2].
(5-HYDROXY-4,6-DIMETHYLPYRIDIN-3-YL)METHYL DIHYDROGEN PHOSPHATE
3,3-Dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide
4-methyl-N-(5-methyl-1,3,4-thiadiazol-2-yl)benzamide
C11H11N3OS (233.06227959999998)
N1-(3-chloro-4-fluorophenyl)-2-(methylthio)acetamide
C9H9ClFNOS (233.00773859999998)
2-(5-Methyl-4H-[1,2,4]triazol-3-ylsulfanyl)-1-phenyl-ethanone
C11H11N3OS (233.06227959999998)
N-[3-methyl-1,3-thiazol-2(3H)-yliden]-N-phenylurea
C11H11N3OS (233.06227959999998)
5-Methyl-7-(trifluoromethyl)-[1,3]thiazolo[4,5-b]pyridin-2-amine
C8H6F3N3S (233.02345119999998)
1-(3-Isocyanatophenyl)-5-(methylsulfanyl)-1H-tetrazole
2-[2-(2-Methylphenyl)-2-oxoethylidene]-1,3-thiazolidin-4-one
Butanamide, N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-3-oxo-
(2S)-2-[[(2S)-2-azaniumyl-2-carboxylatoethyl]azaniumyl]pentanedioate
C8H13N2O6- (233.07735780000002)
(2Z,4E)-2-hydroxy-6-oxo-6-phenoxyhexa-2,4-dienoate
(2S)-2-[(2-Carboxy-2-oxoethyl)amino]pentanedioic acid
(2R)-2-Acetamido-6-hydroxy-2-(sulfanylmethyl)hex-3-enoic acid
N-(4-fluorophenyl)-5-nitropyridin-2-amine
C11H8FN3O2 (233.06005199999998)
1-p-Tolyl-2-(4H-[1,2,4]triazol-3-ylsulfanyl)-ethanone
C11H11N3OS (233.06227959999998)
8-methoxy-N-methyl-2-oxo-1-benzopyran-3-carboxamide
2-(4-Chlorophenyl)-5-(methylamino)-1,3-oxazole-4-carbonitrile
C11H8ClN3O (233.03558679999998)
2-(2-Chlorophenyl)-5-(methylamino)-1,3-oxazole-4-carbonitrile
C11H8ClN3O (233.03558679999998)
2-O,3-dimethylflaviolin-7-olate
An organic anion that is the conjugate base of 2-O,3-dimethylflaviolin, obtained by deprotonation of the 7-hydroxy group. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).
(2S)-2-[2-(2-azaniumylethylamino)-2-oxoethyl]-2-hydroxybutanedioate
C8H13N2O6- (233.07735780000002)
(4Z,7Z)-deca-4,7-dien-1-yl sulfate
An organosulfate oxoanion that is the conjugate base of (4Z,7Z)-deca-4,7-dien-1-yl hydrogen sulfate. It has been isolated from Daphnia pulex and has been shown to cause morphological changes in the green alga Scenedesmus gutwinskii.
(2E,4Z)-2-hydroxy-6-(2-hydroxyphenyl)-6-oxohexa-2,4-dienoate
(2E,4E)-6-(2-aminophenyl)-2-hydroxy-6-oxohexa-2,4-dienoic acid
Dopamine 3-sulfate
An aryl sulfate that is dopamine in which the phenolic hydrogen at position 3 has been replaced by a sulfo group.
dopamine 3-O-sulfate zwitterion
A zwitterion obtained by transfer of a proton from the sulfonyl to the amino group of dopamine 3-O-sulfate; major species at pH 7.3.
dopamine 4-O-sulfate
An aryl sulfate that is dopamine in which the phenolic hydrogen at position 4 has been replaced by a sulfo group.
dopamine 4-O-sulfate zwitterion
A zwitterion obtained by transfer of a proton from the sulfonyl to the amino group of dopamine 4-O-sulfate; major species at pH 7.3.
(-)-chuangxinmycin
A thiinoindole that is 3,5-dihydro-2H-thiino[4,3,2-cd]indole which is substituted at positions 2 and 3 by carboxy and methyl groups, respectively (the 2R,3S diastereoisomer).
5-[(5-hydroxypyridin-3-yl)methoxy]benzene-1,3-diol
(3s)-3-hydroxy-3-methyl-2h-[1,3]thiazolo[3,2-a]indole-9-carbaldehyde
10-amino-9-chloro-2-methyl-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1(12),3,5,7,9-pentaen-11-one
C11H8ClN3O (233.03558679999998)
(5-hydroxy-4,6-dimethylpyridin-3-yl)methoxyphosphonic acid
(2e)-n-methyl-n-[(1z)-2-(methylsulfanyl)ethenyl]-3-phenylprop-2-enamide
C13H15NOS (233.08742999999998)
(2e)-n-methyl-n-[(1e)-2-(methylsulfanyl)ethenyl]-3-phenylprop-2-enamide
C13H15NOS (233.08742999999998)
2-[2-(methylamino)phenyl]-1,3-thiazole-4-carboximidic acid
C11H11N3OS (233.06227959999998)
(2e)-n-methyl-3-(methylsulfanyl)-n-[(1e)-2-phenylethenyl]prop-2-enamide
C13H15NOS (233.08742999999998)
n-methyl-n-[2-(methylsulfanyl)ethenyl]-3-phenylprop-2-enamide
C13H15NOS (233.08742999999998)